WallStreetZen

NASDAQ: AZN
Astrazeneca Plc Stock Forecast, Predictions & Price Target

Analyst price target for AZN

Based on 1 analysts offering 12 month price targets for Astrazeneca Plc.
Min Forecast
$63.00+10.06%
Avg Forecast
$63.00+10.06%
Max Forecast
$63.00+10.06%

Should I buy or sell AZN stock?

Based on 6 analysts offering ratings for Astrazeneca Plc.
Strong Buy
Strong Buy
4 analysts 66.67%
Buy
1 analysts 16.67%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

AZN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Jefferies
Bottom 18%
18
Strong BuyUpgradesN/AN/A2021-03-16
UBS
Bottom 38%
38
Strong BuyUpgradesN/AN/A2021-02-25
Deutsche Bank
Bottom 49%
49
Strong BuyInitiates Coverage OnN/AN/A2021-01-15
Anonymous
Morgan Stanley
Strong BuyUpgradesN/AN/A2020-12-07
SVB Leerink
Bottom 1%
1
BuyMaintains$63.00+10.06%2021-07-16
Argus Research
Top 31%
70
HoldDowngradesN/AN/A2021-04-12

1 of 1

Forecast return on equity

Is AZN forecast to generate an efficient return?
Company
38.71%
Industry
73.39%
Market
59.49%
AZN's Return on Equity is forecast to be high in 3 years (38.71%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is AZN forecast to generate an efficient return on assets?
Company
8.24%
Industry
16.5%
Market
15.35%
AZN is forecast to generate lower Return on Assets (8.24%) than the US Drug Manufacturers - General industry average (16.5%)
Forecast

AZN earnings per share forecast

What is AZN's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$2.58+78.99%
Avg 2 year Forecast
$3.39+135.28%
Avg 3 year Forecast
$4.12+186.11%
AZN's earnings are forecast to grow at an exceptional rate of 42.18% per year
Forecast

AZN revenue forecast

What is AZN's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$33.0B+11.91%
Avg 2 year Forecast
$41.2B+39.61%
Avg 3 year Forecast
$44.0B+49.02%
AZN's revenue is forecast to grow at a rate of 14.22% per year, which is not exceptional
Forecast

AZN earnings growth forecast

How is AZN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
42.18%
Industry
29.46%
Market
18.23%
AZN's earnings are forecast to grow faster (42.18% per year) than the US Drug Manufacturers - General industry average (29.46%)
Forecast
AZN's earnings are forecast to grow faster (42.18% per year) than the US market average (18.23%)
Forecast
AZN's earnings are forecast to grow faster (42.18% per year) than the risk-free savings rate (1.2%)
Forecast

AZN revenue growth forecast

How is AZN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
14.22%
Industry
5.1%
Market
13.54%
AZN's revenues are forecast to grow faster (14.22% per year) than the US Drug Manufacturers - General industry average (5.1%)
Forecast
AZN's revenues are forecast to grow faster (14.22% per year) than the US market average (13.54%)
Forecast

Astrazeneca Stock Forecast FAQ

Is Astrazeneca Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: AZN) stock is to Strong Buy AZN stock.

Out of 6 analysts, 4 (66.67%) are recommending AZN as a Strong Buy, 1 (16.67%) are recommending AZN as a Buy, 1 (16.67%) are recommending AZN as a Hold, 0 (0%) are recommending AZN as a Sell, and 0 (0%) are recommending AZN as a Strong Sell.

What is AZN's earnings growth forecast for 2021-2023?

(NASDAQ: AZN) Astrazeneca's forecast annual earnings growth rate of 42.18% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 29.46%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 18.23%.

Astrazeneca's earnings in 2021 is $3,768,000,000.On average, 4 Wall Street analysts forecast AZN's earnings for 2021 to be $3,381,680,000, with the lowest AZN earnings forecast at $3,135,680,000, and the highest AZN earnings forecast at $3,608,000,000. On average, 5 Wall Street analysts forecast AZN's earnings for 2022 to be $4,445,056,000, with the lowest AZN earnings forecast at $3,673,600,000, and the highest AZN earnings forecast at $5,011,840,000.

In 2023, AZN is forecast to generate $5,405,440,000 in earnings, with the lowest earnings forecast at $4,605,120,000 and the highest earnings forecast at $5,904,000,000.

What is AZN's revenue growth forecast for 2021-2023?

(NASDAQ: AZN) Astrazeneca's forecast annual revenue growth rate of 14.22% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.1%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 13.54%.

Astrazeneca's revenue in 2021 is $29,528,000,000.On average, 3 Wall Street analysts forecast AZN's revenue for 2021 to be $43,354,877,312,000, with the lowest AZN revenue forecast at $40,737,600,000,000, and the highest AZN revenue forecast at $46,932,864,000,000. On average, 3 Wall Street analysts forecast AZN's revenue for 2022 to be $54,086,525,632,000, with the lowest AZN revenue forecast at $49,732,672,000,000, and the highest AZN revenue forecast at $57,993,024,000,000.

In 2023, AZN is forecast to generate $57,730,002,112,000 in revenue, with the lowest revenue forecast at $50,826,880,000,000 and the highest revenue forecast at $63,220,032,000,000.

What is AZN's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: AZN) forecast ROA is 8.24%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.5%.

What is AZN's Price Target?

According to 1 Wall Street analysts that have issued a 1 year AZN price target, the average AZN price target is $63.00, with the highest AZN stock price forecast at $63.00 and the lowest AZN stock price forecast at $63.00.

On average, Wall Street analysts predict that Astrazeneca's share price could stay at $63.00 by Jul 16, 2022. The average Astrazeneca stock price prediction forecasts a potential downside of N/A from the current AZN share price of $57.24.

What is AZN's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: AZN) Astrazeneca's current Earnings Per Share (EPS) is $1.44. On average, analysts forecast that AZN's EPS will be $2.58 for 2021, with the lowest EPS forecast at $2.39, and the highest EPS forecast at $2.75. On average, analysts forecast that AZN's EPS will be $3.39 for 2022, with the lowest EPS forecast at $2.80, and the highest EPS forecast at $3.82. In 2023, AZN's EPS is forecast to hit $4.12 (min: $3.51, max: $4.50).

What is AZN's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: AZN) forecast ROE is 38.71%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.